A Study to Learn About the Study Medicine Bosulif in Adult Patients With Chronic Myeloid Leukemia(CML).
Recruiting
600 enrolled
Screening Study for KIT D816V Mutated Mast Cell Disease in Select Populations
Recruiting
450 enrolled
A Study of Patient Characteristics, Co-Morbidities, and Treatment Patterns in Chronic Myeloid Leukemia Patients in Kuwait
Not yet recruiting
400 enrolled
ACROBAT
Active not recruiting
307 enrolled
A Non-Interventional Study in Participants With Indolent Systemic Mastocytosis (ISM) in Germany
Recruiting
80 enrolled
ASSURE-3
Active not recruiting
201 enrolled
ROPE
Recruiting
200 enrolled
An Observational Study in Participants With Indolent Systemic Mastocytosis (ISM)
Not yet recruiting
150 enrolled
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Recruiting
50,000 enrolled
Treatment Patterns and Outcomes Among Patients With Chronic Myeloid Leukemia (CML) in All Lines of Treatment
Completed
2,298 enrolled
Prospero
Active not recruiting
242 enrolled
A Real-world Study About the Impact of Adverse Events (AEs) on Treatment Adjustments, Healthcare Resource Use, and Costs Among Chronic Myeloid Leukemia Patients
Completed
2,546 enrolled
A Study of Real-world Treatment and Burden of Chronic Myeloid Leukemia Patients in Japan
Completed
754 enrolled
HOPE
Recruiting
10 enrolled
Connect® Myeloid Disease Registry
Terminated
2,013 enrolled
CARCML
Recruiting
240 enrolled
SANGUINE
Unknown
3,000 enrolled
RevlimidPMS
Completed
28 enrolled
Asciminib RMP Study
Recruiting
100 enrolled
ROOT
Completed
167 enrolled
ABL-2022-03
Completed
2,043 enrolled
Evaluation of IFNγ and Inflammatory Mediators in Patients With Malignancy-Associated Hemophagocytic Lymphohistiocytosis
Completed
40 enrolled 43 charts
Long-term Follow-up Study in Patients Previously Treated With a Mustang Bio CAR-T Cell Investigational Product.
Terminated
3 enrolled
PAVE
Completed
467 enrolled
BLF
Completed
702 enrolled
OMNI
Terminated
3 enrolled
Special Drug Use-results Surveillance of Scemblix Tablets
Completed
550 enrolled
METER
Completed
998 enrolled
Real-World Usage of Asciminib Among Patients With Chronic Myeloid Leukemia in Chronic Phase in the United States Using a Large Claims Database
Completed
425 enrolled
Study to Evaluate Chronic Myeloid Leukemia Treatment Landscape and Real-life Treatment Outcomes in Hungary: Analysis of National Health Insurance Fund Database
Completed
1,484 enrolled 6 charts
A Study To Describe The Real World Use Of Bosutinib In The UK And Netherlands
Completed
87 enrolled 22 charts
Observational Study on CML Patients in Any Phase of the Disease Treated With Ponatinib (Iclusig®)
Completed
120 enrolled
NOFRETETE
Completed
222 enrolled
Real-World Disease Management and Outcomes in Chronic Myeloid Leukaemia
Completed
555 enrolled
DIM Vidaza
Completed
290 enrolled
Clinical Outcomes of 3L+ Therapies Among Patients With Chronic Myeloid Leukemia and Those With T315I Mutation
Completed
164 enrolled
Iclusig PMS in CML or Ph+ALL Patients
Unknown
50 enrolled
French Study to Highlight the Unmet Treatment Needs of 3L+ CP-CML and With T315I-mutated CML Patients
Completed
200 enrolled
Study Conducted Among Patients With CML
Completed
3,234 enrolled
Ruxolitinib for Polycythemia Vera in Patients Resistant to or Intolerant of Hydroxyurea.
Completed
1,576 enrolled
SIMPLICITY
Completed
1,494 enrolled
Study of Chinese Newly Diagnosed Participants With Philadelphia Chromosome-Positive (Ph+) Chronic Myeloid Leukemia in Chronic Phase (CML-CP)
Completed
463 enrolled
A Study of Dasatinib Management Among CP-CML (Chronic Phase, Chronic Myeloid Leukemia) Participants Initiating Dasatinib in a Real Life Setting
Completed
177 enrolled
A Study of Special Use Results Surveillance of Revlimid 5mg Capsules
Completed
4,626 enrolled
A Study to Analyze the Occurrence of Transformation From Myelodysplastic Syndrome to Acute Myeloid Leukemia in Patients With Myelodysplastic Syndrome Who Received Revlimid® 5 mg Capsules and Who Are Continuing or no Longer Continuing Revlimid Treatment
Completed
84 enrolled
Myelofibrosis and Essential Thrombocythemia Observational Study (MOST)
Completed
1,469 enrolled
Iclusig® (Ponatinib) in Clinical Practice for the Treatment of Chronic Myeloid Leukemia or Ph+ Acute Lymphoblastic Leukemia in Belgium
Completed
80 enrolled
(ANSWer)
Completed
119 enrolled
Retrospective Study Assessing the Effect of Avapritinib Versus Best Available Therapy in Patients With AdvSM
Completed
317 enrolled
CALLS: CML and Ph+ALL Low Level Mutation Prevalence Survey
Completed
427 enrolled